Similar findings have also been reported in vivo: chronic administration of a natural NRF2 activator, sulforaphane, did not enhance tumorigenesis in the KRASG12D mouse lung cancer model, despite increasing the levels of NRF2 target genes in lung tissue [72]. This evidence concerns the gene NFE2L2 and lung carcinoma.